Skip to main content
. Author manuscript; available in PMC: 2014 Aug 20.
Published in final edited form as: J Neuroimmunol. 2010 Jun;223(0):55–64. doi: 10.1016/j.jneuroim.2010.04.002

Fig. 6.

Fig. 6

Effect of CS-A and CSPG-DS on TNFα production in splenocytes. (A) TNFα level in the sera of control mice that did not receive MOG35-55 immunization and Pertussis toxin or EAE mice, on day 7, treated with or without CSPG-DS and CS-A. (B) TNFα expression at mRNA level in splenocytes from control or EAE mice, on day 7, with or without CSPG-DS or CS-A treatment. (C) Detection of TNFα release from splenocytes after in vitro stimulation with MOG35-55 in the absence or presence of CSPG-DS or CS-A for four days. Data were presented as mean ± SEM (error bas) of multiple experiments from three mice/group.